Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ChiCTR1900023042Phase 4Recruiting
Phase 4, randomised, double-blind trial in infertility and Diminished Ovarian Reserve (DOR) comparing Zishen Yutai Pill Group with Placebo Group (2 arms). Primary endpoint: High quality embryo number rate. Started May 2019; status: recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on ChiCTR1900023042.